Advanced Filters
noise

Roeselare, Australia Clinical Trials

A listing of Roeselare, Australia clinical trials actively recruiting patients volunteers.

Found 64,712 clinical trials
N Natasha R. Holt

MYLUNG Consortium Part 3: Observational Study

This longitudinal study looks to quantify the testing timeline, operational barriers, and outcomes of biomarker-guided therapy in a large, community-based, and largely unselected patient population with early stage and advanced stage, treatment-naive non-small cell lung cancer, whether squamous or non-squamous.

18 years of age All Phase N/A
J Juhani KE Airaksinen, MD, PhD

TROPOnin FRAGMentation in Myocardial Injury Study

Troponin T (TnT) is a part of the troponin protein complex that principally exists in cardiac and skeletal muscle cells and is widely used as diagnostic biomarker for myocardial injury and, thus, myocardial infarction (MI). Elevated TnT levels can, however, be observed in the presence of other clinical conditions such …

18 years of age All Phase N/A
W Wenhao Zhou, Doctor

Developing Metagenomic Approaches to Identify the Causes of Pediatric Infectious Diseases

Infectious diseases remain leading causes of mortality and morbidity in children. Rapid and accurate diagnosis of infectious diseases in children is important for developing an effective treatment and management strategy. However, the current diagnosis of infectious agents mainly depends on culture and molecular testing. Both of the methods either has …

- 16 years of age All Phase N/A

Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer

It is a non-randomized, multicentric, cohort study, combined with a biological sample collection, a clinical data collection and with a genetic and immunologic biomarkers study. The ProfiLER program aims to implement a personalized cancer medicine approach by proposing to establish the genetic and immunologic profile of the tumor for patients …

years of age All Phase N/A

Tissue Collection Framework To Improve Outcomes In Solid Tumours

Background Cancer therapies have significantly improved over the last decades, allowing cancer specialists to keep cancer under control for longer than ever before. However, metastatic cancer still develops in a large number of patients and drug resistance occurs in the majority of them after an initial period of response and …

18 years of age All Phase N/A

PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing

Objectives This protocol addresses the first phase of a larger project funded by the Patient-Centered Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer screening with low-dose computed tomography (CT). A separate IRB protocol will be submitted for the larger, comparative study. In this initial development …

55 - 80 years of age All Phase N/A
F Frederic Frappereau

Data Collection and Evaluation of OptiBP Under Investigational Use

The purpose of this study is to collect data to develop and evaluate the use of state-of-the-art machine learning approaches within a mobile phone application for the estimation of blood pressure.

18 years of age All Phase N/A
E Emily L Klawson, MS

MyPaTH Story Booth

The MyPaTH Story Booth will use an (audio) "document" approach to elicit in depth experiential knowledge or perspectives from patients and caregivers by recording their personal stories.

18 - 99 years of age All Phase N/A

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

18 - 65 years of age All Phase 2
M María Martín, MD

Thoracic Tumours Register

Observational, multicenter study in patients with lung cancer and other thoracic tumors. The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response to chemotherapeutic agents …

years of age All Phase N/A

Simplify language using AI